Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Keqiang Chai"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-16 (2024)
Abstract The incidence of prostate cancer (PCa), the most prevalent malignancy, is currently at the forefront. RNA modification is a subfield of the booming field of epigenetics. To date, more than 170 types of RNA modifications have been described,
Externí odkaz:
https://doaj.org/article/3fc780ee8d5b41b8a6c356c3751c4a9d
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Prostate cancer is a major contributor to male cancer-related mortality globally. It has a particular affinity for the skeletal system with metastasis to bones seriously impacting prognosis. The identification of prostate cancer biomarkers can signif
Externí odkaz:
https://doaj.org/article/08f54114036145d2aedc2244e9a58da8
Autor:
Zhengchao Zhang, Dong Li, Heng Yun, Jie Tong, Wei Liu, Keqiang Chai, Tongwei Zeng, Zhenghua Gao, Yongqiang Xie
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
At present, a large number of studies have demonstrated that c-Met generally exerts a crucial function of promoting tumor cells proliferation and differentiation in digestive system tumors. c-Met also mediates tumor progression and drug resistance by
Externí odkaz:
https://doaj.org/article/630b47cd92004e66926378c4d84bbbc6
Autor:
Zhengchao Zhang, Dong Li, Heng Yun, Wei Liu, Keqiang Chai, Jie Tong, Tongwei Zeng, Zhenghua Gao, Yongqiang Xie
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
In recent years, with the breakthrough of CAR-T cells in the treatment of hematological tumors, they are increasingly being used to treat solid tumors, including urologic neoplasms. There are many relatively specific targets for urologic neoplasms, e
Externí odkaz:
https://doaj.org/article/d8f0f54628e14bc794e67ba4259cd358